My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 141

    1.

    Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy.

    Kusunoki H, Miyata S, Ohara T, Liu BF, Uriuhara A, Kojima H, Suzuki K, Miyazaki H, Yamashita Y, Inaba K, Kasuga M.

    Diabetes Care. 2003 Jun;26(6):1889-94.PMID: 12766129 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of glycemic control on plasma 3-deoxyglucosone levels in NIDDM patients.

    Hamada Y, Nakamura J, Fujisawa H, Yago H, Nakashima E, Koh N, Hotta N.

    Diabetes Care. 1997 Sep;20(9):1466-9.PMID: 9283799 [PubMed - indexed for MEDLINE]Related articles

    3.

    Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.

    Aso Y, Inukai T, Tayama K, Takemura Y.

    Acta Diabetol. 2000;37(2):87-92.PMID: 11194933 [PubMed - indexed for MEDLINE]Related articles

    4.

    Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.

    Hamada Y, Nakamura J, Naruse K, Komori T, Kato K, Kasuya Y, Nagai R, Horiuchi S, Hotta N.

    Diabetes Care. 2000 Oct;23(10):1539-44.PMID: 11023149 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Serum 8-hydroxy-guanine levels are increased in diabetic patients.

    Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK.

    Diabetes Care. 2001 Apr;24(4):733-7.PMID: 11315839 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Urinary excretion of advanced glycation endproducts in patients with type 2 diabetes and various stages of proteinuria.

    Turk N, Mornar A, Mrzljak V, Turk Z.

    Diabetes Metab. 2004 Apr;30(2):187-92.PMID: 15223992 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A novel advanced glycation index and its association with diabetes and microangiopathy.

    Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V.

    Metabolism. 2005 Aug;54(8):1002-7.PMID: 16092048 [PubMed - indexed for MEDLINE]Related articles

    8.

    Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum.

    Niwa T, Takeda N, Yoshizumi H, Tatematsu A, Ohara M, Tomiyama S, Niimura K.

    Biochem Biophys Res Commun. 1993 Oct 29;196(2):837-43.PMID: 8240359 [PubMed - indexed for MEDLINE]Related articles

    9.

    Elevated serum levels of 3-deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients.

    Niwa T, Takeda N, Miyazaki T, Yoshizumi H, Tatematsu A, Maeda K, Ohara M, Tomiyama S, Niimura K.

    Nephron. 1995;69(4):438-43.PMID: 7777110 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Transcapillary filtration of plasma proteins in patients with diabetes type II microangiopathy complications]

    Muszyńska-Lachota I.

    Ann Acad Med Stetin. 2002;48:255-69. Polish. PMID: 14601482 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications.

    Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, Epaminonda P, Masserini B, Beck-Peccoz P, Orsi E, Ambrosi B, Arosio M.

    Diabetes Care. 2007 Jan;30(1):83-8.PMID: 17192338 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

    Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction.

    Yamada H, Miyata S, Igaki N, Yatabe H, Miyauchi Y, Ohara T, Sakai M, Shoda H, Oimomi M, Kasuga M.

    J Biol Chem. 1994 Aug 12;269(32):20275-80.PMID: 8051120 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Gas chromatographic-mass spectrometric determination of erythrocyte 3-deoxyglucosone in diabetic patients.

    Tsukushi S, Kajita M, Nakamura S, Niwa T.

    J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Aug 25;776(1):133-7.PMID: 12127334 [PubMed - indexed for MEDLINE]Related articles

    15.

    Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

    Romero P, Salvat M, Fernández J, Baget M, Martinez I.

    J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.PMID: 17331857 [PubMed - indexed for MEDLINE]Related articles

    16.

    Association of hypoglutathionemia with reduced Na+/K+ ATPase activity in type 2 diabetes and microangiopathy.

    Sampathkumar R, Balasubramanyam M, Tara C, Rema M, Mohan V.

    Mol Cell Biochem. 2006 Jan;282(1-2):169-76.PMID: 16317524 [PubMed - indexed for MEDLINE]Related articles

    17.

    Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.

    Tsukushi S, Katsuzaki T, Aoyama I, Takayama F, Miyazaki T, Shimokata K, Niwa T.

    Kidney Int. 1999 May;55(5):1970-6.PMID: 10231461 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.

    Romero P, Baget M, Mendez I, Fernández J, Salvat M, Martinez I.

    J Diabetes Complications. 2007 May-Jun;21(3):172-80.PMID: 17493551 [PubMed - indexed for MEDLINE]Related articles

    19.

    Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy--a nationwide 5-year-study in Japan.

    Murase Y, Imagawa A, Hanafusa T, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H.

    Diabetologia. 2007 Mar;50(3):531-7. Epub 2007 Jan 18.PMID: 17235525 [PubMed - indexed for MEDLINE]Related articles

    20.

    Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

    Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ.

    Diabetologia. 2006 Nov;49(11):2756-62. Epub 2006 Sep 13.PMID: 16969649 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity